Hot flashes and night sweats are among the most recognizable symptoms of perimenopause and menopause. A hot flash can arrive suddenly, producing an intense wave of heat across the face, neck, chest, and upper body followed by sweating, flushing, palpitations, anxiety, or chills. When the same vasomotor event occurs during sleep, it is commonly called a night sweat. These episodes can repeatedly wake someone from sleep, leaving them exhausted even when the individual flash lasts only a few minutes. The American College of Obstetricians and Gynecologists estimates that as many as eight in ten women experience hot flashes around menopause, and symptoms can continue for years rather than disappearing immediately after the final menstrual period.
Cannabis is increasingly being used by midlife women hoping to manage insomnia, anxiety, joint discomfort, hot flashes, and other menopausal symptoms. Surveys show that many users believe marijuana is helpful, particularly for sleep. What remains missing is convincing clinical evidence showing that THC, CBD, or dispensary cannabis actually reduces the frequency or severity of menopausal vasomotor symptoms. That distinction is critical. Someone may sleep more easily after THC or feel less bothered by an episode without experiencing fewer hot flashes biologically. Current evidence-based menopause guidance therefore does not consider marijuana an established treatment for hot flashes or night sweats.
Why Hot Flashes and Night Sweats Happen
Hot flashes are fundamentally a problem of temperature regulation rather than simply being the body “getting too hot.” Falling and fluctuating estrogen levels during the menopausal transition alter signaling within the hypothalamus, the brain region responsible for maintaining body temperature. Modern research has focused heavily on kisspeptin-neurokinin B-dynorphin, or KNDy, neurons. As estrogen levels decline, this neural system becomes more active, effectively narrowing the temperature range the brain regards as comfortable. A very small change in core temperature can then trigger rapid skin blood-vessel dilation and sweating as the body attempts to release heat.
Night sweats are essentially vasomotor symptoms occurring during sleep. A person may suddenly become hot, sweat heavily, throw off the covers, and then feel chilled as the episode subsides. Repeated events can fragment sleep even if total time in bed appears adequate. This helps explain why menopausal women may simultaneously complain of overheating, insomnia, daytime fatigue, poor concentration, and irritability. The problem is therefore more complicated than merely lowering the thermostat or taking something sedating before bed. Effective vasomotor treatments act either on the hormonal changes contributing to the thermoregulatory disturbance or on neurological pathways involved in generating the flash itself.
Why Cannabis Seems Like a Plausible Treatment
There are biological reasons scientists have been interested in cannabinoids and thermoregulation. The endocannabinoid system is active in the hypothalamus and other brain regions involved in temperature control. THC activates CB1 cannabinoid receptors, and experimental research has shown that cannabinoid receptor activation can influence body temperature. Animal experiments have demonstrated THC- and cannabinoid-induced hypothermia through CB1 receptors within the preoptic anterior hypothalamus, a major thermoregulatory center.
Those findings are scientifically interesting but do not demonstrate that marijuana treats menopausal hot flashes. Much of the thermoregulation research has involved animals, synthetic cannabinoid agonists, unusually high exposures, or experiments unrelated to menopause. Human research is sparse and inconsistent. An older controlled experiment involving marijuana and cold exposure, for example, found little overall change in core heat content despite several physiological effects. The biology therefore provides a reason to study cannabis—not a reason to assume that lowering body temperature with THC will correct the KNDy-neuron dysfunction associated with menopausal vasomotor symptoms.
What Women Using Cannabis During Menopause Report
One of the larger studies of cannabis use during menopause came from researchers affiliated with McLean Hospital and Harvard Medical School. Their survey included 258 perimenopausal and postmenopausal participants. Most reported current cannabis use, and almost 79% said they were using cannabis for menopause-related symptoms. The most commonly targeted symptom was sleep disturbance, reported by 67.4%, followed by mood or anxiety symptoms. Smoking and edible cannabis were both common. The researchers also found that perimenopausal participants reported a greater burden of vasomotor symptoms, including hot flashes, than postmenopausal participants.
Researchers at the University of Alberta found a similar pattern in a much larger survey of 1,485 women aged 35 and older. About one-third were current cannabis users, and more than three-quarters of those users reported medical reasons for use. Sleep was again the most common reason, cited by 65%, followed by anxiety and muscle or joint discomfort. About 74% of current users perceived cannabis as helpful for their symptoms. These results show that women are clearly experimenting with marijuana during menopause, but they do not establish efficacy. Participants chose their own products and doses, knew they were using cannabis, and were not randomized against placebo. Women with more troublesome symptoms may also be more likely to seek cannabis in the first place.
Direct Evidence for Cannabis and Hot Flashes Is Surprisingly Thin
When researchers performed a systematic review specifically examining cannabis for menopausal symptoms, they initially identified 564 publications. Only three met the criteria for inclusion. One was a tiny controlled experiment involving only ten postmenopausal women, another evaluated hot flashes and insomnia among women living with HIV, and the third studied women’s expectations regarding cannabis rather than demonstrating treatment efficacy. The reviewers concluded that there was insufficient evidence to determine whether cannabis effectively reduces menopausal vasomotor symptoms.
This remains one of the central problems with claims about marijuana and menopause. There are numerous surveys describing what women use, why they use it, and whether they believe it helps, but essentially no robust body of randomized trials measuring hot-flash frequency before and after standardized THC or CBD treatment. A 2025 national survey from the Harvard-affiliated McLean MIND program further demonstrated that regular cannabis use is occurring among menopausal individuals, particularly among those with greater symptom burdens, but again did not establish that cannabis caused symptom improvement.
Current Menopause Guidelines Do Not Recommend Cannabinoids
The strongest clinical guidance is unusually clear on this point. The Menopause Society‘s 2023 evidence-based position statement reviewed nonhormonal treatments for vasomotor symptoms and specifically listed cannabinoids among treatments that are not recommended, assigning the evidence Level II because of limited or inconsistent data. In contrast, the panel recommended cognitive behavioral therapy, clinical hypnosis, SSRIs and SNRIs, gabapentin, and the neurokinin drug fezolinetant based on stronger evidence. Oxybutynin, weight loss, and stellate ganglion block received varying levels of support as well.
“Not recommended” in this context does not mean research has proven cannabis ineffective. Rather, researchers do not yet have adequate evidence demonstrating that it works well enough to be recommended as a vasomotor treatment. This is an important difference. Future clinical trials might identify a cannabinoid, dose, or formulation that meaningfully reduces hot flashes. At present, however, marijuana remains much less studied than established hormone and nonhormone therapies.
THC May Help Sleep Without Necessarily Stopping Night Sweats
For some women, the perceived benefit of cannabis may have more to do with sleep than with hot flashes themselves. THC can produce sedation and shorten perceived sleep onset in some users. Studies of cannabis in chronic pain and other conditions have sometimes reported better sleep quality or fewer sleep disturbances. NCCIH cautions, however, that researchers often cannot determine whether cannabinoids directly improved sleep or whether people simply slept better because another symptom improved. Evidence supporting cannabinoids for sleep disorders remains insufficient and inconsistent.
That distinction matters particularly with night sweats. Imagine that someone normally wakes fully during every vasomotor episode and remains awake for 30 minutes. If THC makes that person more sedated, she may return to sleep faster and report that marijuana “fixed” her night sweats even though the underlying vasomotor events are occurring at the same frequency. That improvement in sleep could still be meaningful, but it is different from a medication that actually reduces nocturnal hot flashes. Clinical trials need objective or carefully recorded vasomotor measurements to separate these outcomes.
THC vs CBD for Menopause Symptoms
THC and CBD should not be grouped together as though they have identical effects. THC is the principal intoxicating cannabinoid and acts directly on CB1 receptors. It can produce relaxation, drowsiness, altered sensory perception, increased appetite, dizziness, impaired coordination, or anxiety depending on the dose and individual. Because CB1 receptors participate in thermoregulation, THC is biologically more plausible than CBD as a direct modifier of temperature signaling. Yet that theoretical advantage has not translated into convincing clinical evidence for menopausal hot flashes.
CBD does not normally produce a traditional marijuana high, which makes it especially attractive to women who want symptom relief without intoxication. Unfortunately, direct evidence for CBD and menopausal vasomotor symptoms is even weaker. CBD products are frequently promoted for anxiety and sleep, but those potential secondary effects should not be confused with demonstrated reductions in hot-flash frequency. NCCIH notes that CBD can also cause sleepiness, gastrointestinal effects, liver injury, and drug interactions, particularly at higher doses. Nonintoxicating does not mean pharmacologically inactive.
Cannabis Risks Can Matter More During Midlife
For otherwise healthy adults, occasional cannabis use may produce relatively minor adverse effects, but risk becomes more individualized during midlife. THC can cause dizziness, impaired balance, anxiety, cognitive slowing, and increases in heart rate. These effects may become particularly noticeable when combined with alcohol, sleep medications, benzodiazepines, gabapentin, opioids, or other sedating drugs. Someone using marijuana at night because of hot flashes could therefore sleep better but also face greater impairment if she gets out of bed during the night.
CBD creates a different concern because it can interfere with liver enzymes used to metabolize numerous prescription medicines. Women going through menopause may simultaneously use antidepressants, statins, blood-pressure medications, anticoagulants, thyroid medicine, or other drugs with interaction potential. Commercial cannabis products also vary substantially in potency and labeling accuracy. NCCIH warns that retail cannabinoid products sometimes contain cannabinoid concentrations that differ considerably from their labels and can contain contaminants or unexpected THC.
Smoking adds respiratory exposure that is unnecessary for treating a nonpulmonary condition, while vaping carries separate concerns. Edibles avoid smoke but have delayed, sometimes unpredictable onset and longer-lasting intoxication. For someone interested specifically in nighttime symptoms, these differences can matter: a high-dose edible taken shortly before bed may remain psychoactive the following morning, whereas inhaled THC acts more quickly but introduces airway exposure.
How Cannabis Compares With Proven Hot-Flash Treatments
Menopausal hormone therapy remains the most effective treatment for hot flashes and night sweats. The Menopause Society and ACOG both identify systemic estrogen—with a progestogen when needed to protect the uterus—as the most effective vasomotor treatment for appropriate candidates. Whether hormone therapy is suitable depends on age, time since menopause, personal health history, type and route of hormone therapy, and conditions such as certain cancers, blood clots, cardiovascular disease, or liver disease.
For women who do not want or should not use hormone therapy, the evidence base has expanded considerably. SSRIs and SNRIs, gabapentin, and oxybutynin have demonstrated benefit. Fezolinetant became the first FDA-approved neurokinin-3 receptor antagonist for moderate-to-severe menopausal vasomotor symptoms in 2023, although the FDA later added a boxed warning concerning rare serious liver injury and requires liver monitoring. In October 2025, the FDA approved elinzanetant (Lynkuet), a dual neurokinin-1 and neurokinin-3 receptor antagonist, following trials involving more than 1,400 participants. These drugs directly target neural systems involved in menopausal thermoregulation and have substantially stronger clinical evidence than cannabis.
Night Sweats Are Not Always Menopause
A woman in her late 40s or 50s who suddenly develops night sweats may reasonably suspect menopause, particularly if menstrual cycles are becoming irregular. But not every episode of nighttime sweating is a vasomotor symptom. MedlinePlus lists infections, fever, low blood sugar, anxiety, certain medications, thyroid problems, alcohol, and several other medical conditions among potential causes of excessive sweating. Cancer therapies such as tamoxifen and aromatase inhibitors can also trigger severe hot flashes and night sweats.
Regular drenching night sweats accompanied by unexplained weight loss, fever, persistent cough, chest symptoms, or other significant changes deserve medical evaluation rather than simply being treated with cannabis. The same applies when night sweats begin unexpectedly outside the usual menopausal transition. Marijuana might make a person sleep through a symptom without addressing the condition producing it.
Why Women May Still Report Meaningful Benefit
None of this means women who report improvement with cannabis are necessarily imagining the effect. Menopause is a cluster of interconnected symptoms. Night sweats disturb sleep; inadequate sleep worsens mood, anxiety, fatigue, and pain sensitivity; anxiety can make vasomotor symptoms feel more disruptive. A drug that improves one part of that network could produce a meaningful improvement in overall quality of life even if it does not directly suppress the hot-flash mechanism.
This may explain why surveys consistently find positive perceptions of cannabis despite the absence of convincing vasomotor trials. In the University of Alberta survey, nearly three-quarters of current cannabis users considered it helpful, while the Harvard/McLean study showed that sleep disturbance was the leading symptom being targeted. Those observations deserve further research, particularly randomized trials comparing THC, CBD, balanced formulations, and placebo while recording both hot-flash frequency and sleep outcomes. They do not yet justify calling medical marijuana an evidence-based treatment for menopause.
Final Thoughts on Marijuana for Hot Flashes and Night Sweats
Cannabis is widely being used during perimenopause and menopause, especially for sleep disturbance, anxiety, and general symptom relief. THC interacts with brain systems involved in thermoregulation, giving researchers a biologically plausible reason to investigate it. Surveys from Harvard-affiliated researchers and the University of Alberta also show that many women perceive cannabis as useful during the menopause transition. What is still missing is the most important evidence: good randomized trials demonstrating that THC or CBD actually reduces the number or severity of menopausal hot flashes and night sweats.
For that reason, current evidence does not place marijuana alongside hormone therapy, SSRIs or SNRIs, gabapentin, fezolinetant, elinzanetant, or other established options. The Menopause Society explicitly concluded that cannabinoids should not currently be recommended for vasomotor symptoms because the evidence is insufficient or inconsistent.
For someone already using cannabis, the experience may nevertheless be worth discussing with a clinician in concrete terms: whether it reduces nighttime awakenings, changes perceived hot-flash intensity, improves anxiety, or simply makes sleep easier. THC content, CBD exposure, route of use, medications, cardiovascular history, and daytime impairment all matter. Marijuana may eventually prove useful for selected menopause symptoms, but based on the research available today, the evidence is much stronger that some women use cannabis and believe it helps than that cannabis directly treats the biological process responsible for hot flashes and night sweats.
